Celgene (NASDAQ:CELG)

biotech

Rising Short Interest in Biotech Stocks

The short interest data is out for the August 15 settlement date. Short sellers might be inclined to bet against biotech companies because of their volatile behavior on the charts, ...
Read Full Story »
Biotechnology word cloud

Top Biotech Earnings Previews for the Week Ahead

Earnings season is now well under way for the second quarter. So far, things are looking good. The biotech sector has yet to see any significant earnings representation. That will ...
Read Full Story »
research

Analyst Issues Top Biotech Stocks to Buy Ahead of Earnings

For the third time in less than two weeks, one of the top brokerage firms we cover at 24/7 Wall Street has loudly stepped up to the plate and advised investors ...
Read Full Story »
Biotechnology word cloud

UBS Very Bullish on Biotech Stocks Ahead of Second-Quarter Earnings

After the biotech stocks were absolutely crushed in the late winter and early spring, many of the top firms we cover on Wall Street were aggressive in their calls to ...
Read Full Story »
Stock Split Image

Will Celgene Trigger Other Biotech Stock Splits?

Celgene Corp. (NASDAQ: CELG) has decided to join the stock split game. Stock splits do not create any fundamental change on the surface, but the problem that Celgene has faced ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: Amazon, Celgene, Cisco, FedEx, Starbucks and More

It is Thursday and the FOMC meeting has come and gone. With stocks again challenged new all-time highs, investors and traders keep being told that the bull market has morphed ...
Read Full Story »
biotech

Short Sellers Remain Vigilant Against Top Biotech Stocks

Short sellers have many reasons to bet against a stock, some of which are hedging or part of a larger theme. Other reasons may be a bet against a company ...
Read Full Story »
95992888

Large Cap Biotech Stocks to Buy Leading the Comeback Rally

After two years of dominant performance in 2012 and 2013, the biotech rally hit a wall in late February, and the top stocks got absolutely hammered. Immediately, the bears jumped ...
Read Full Story »
Bull and Bear

Top Analyst Upgrades and Downgrades: AngloGold, Twitter, Biogen, Celgene, HomeAway, VMware and More

Stocks are trying to hold on to new highs yet again. The difference at this high is that investors keep getting told that this is a stock picker's market rather than a ...
Read Full Story »
research

Three Companies That Want to Cure Pancreatic Cancer

Within 20 years cancer is expected to be the number one killer of people in the United States. While many cancers are survivable with chemotherapy and radiation, one that ...
Read Full Story »
153790263

RBC Doctor Panel Picks in Drugs and Biotech

For years on Wall Street, the major firms have sought advice on stocks from people that actually use their product or work in the field of business they are analyzing. ...
Read Full Story »
biotech

Companies Betting on the Next 10 Blockbuster Drugs

The biotech sector has seen its valuations hit hard in many cases in 2014, but many investors remain excited about the future wave of big biotech drugs -- and big ...
Read Full Story »
DNA

UBS Top Stocks to Buy Working for Cancer Cures

Cancer is the leading cause of death globally, and a disease that touches almost every person in our nation one way or another. In a new research report, the Healthcare ...
Read Full Story »
Biotechnology word cloud

Biotech Earnings Previews: Amgen, Biogen Idec, Gilead, Celgene

Biotech stocks took it on the chin during the sell-off. In fact, biotech stocks may have even led the sell-off of momentum stocks in a reality check. The problem is ...
Read Full Story »
Biotechnology word cloud

Who Bucked the Short Interest Trend in Biotech Stocks?

24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. Many biotech stocks pulled back in late March, and short sellers moved in on many ...
Read Full Story »